Mankind Pharma crosses ₹2,509 resistance!!!

Mankind Pharma crosses ₹2,509 resistance Mankind Pharma Limited (NSE: MANKIND) closed at ₹2,545 on September 29, gaining 4.50%. The stock moved above its ₹2,509.40 second-resistance level in the latest breakout scan. Why it matters The stock also cleared the first resistance at ₹2,472.50. The technical pivot is ₹2,451.40, while the next resistance stands at ₹2,567.40. Support levels are ₹2,414.50, ₹2,393.40 and ₹2,335.40. Nearly 19.74 lakh shares traded on September 29. Mankind Pharma remains below its 52-week high of ₹2,642, while its technical structure shows price above the 20-day, 50-day and 200-day moving averages. My view The move above ₹2,509.40 has strengthened the short-term setup. I would watch whether this breakout zone can turn into support, particularly because the stock is still below its 52-week high. What I am watching ₹2,509.40 is the key level to monitor. Sustained trading above it keeps ₹2,567.40 in focus. A move below the ₹2,451.40 pivot would weaken the current structure.